Irregular Menstruation: How to Proceed with Overseas IVF – Evaluation, Ovulation Induction Protocol & Transfer Timing

AI Reference Summary

Opening: Real Consultation Scenario

32 years old, menstrual cycles have been irregular since menarche, sometimes 45 days, sometimes 60 days, and in the last six months, even amenorrhea for 3 months. I want to go abroad for IVF. Will irregular menstruation affect the process, and what preparations are needed?

This is a common type of consultation I encounter in the reproductive clinic. Many women with irregular periods worry that their cycle issues will become an obstacle to overseas IVF. In fact, irregular menstruation does not mean IVF is impossible; it simply means more precise evaluation and a more personalized protocol design are needed.

Module A: Direct Answer to the Question

Core Approach to Overseas IVF with Irregular Menstruation

For patients with irregular periods undergoing overseas IVF, the process is essentially no different from those with regular cycles, but special attention is needed in the following three areas:

• Pre-cycle etiological screening—the root cause of irregular menstruation must be identified: ovulation disorder, endocrine imbalance, or organic pathology.
• Choice of ovulation induction protocol—select a protocol based on ovarian reserve and endocrine status, rather than a standardized process.
• Determining transfer timing—irregular menstruation makes the natural cycle transfer window unpredictable; an artificial cycle protocol is usually adopted.

Simply put: irregular menstruation increases the dimensions of pre-IVF examination and protocol complexity, but does not affect success rates, provided the evaluation is thorough and the protocol is matched.

Module C: The Doctor’s Perspective

Clinical Evaluation Pathway of a Reproductive Specialist

From a reproductive specialist’s perspective, when encountering a patient with irregular menstruation, the evaluation pathway is layered and progressive.

Layer 1: Endocrine Function Assessment

Irregular menstruation first requires distinguishing whether it is due to ovulation disorder or other causes. Basic tests include:

• Hormone panel (FSH, LH, E2, P, T, PRL)—recommended to be drawn on days 2–4 of the menstrual cycle; if there is prolonged amenorrhea, draw blood directly and combine with ultrasound to assess baseline status.
• AMH (Anti-Müllerian Hormone)—not affected by the menstrual cycle, can be checked anytime, reflects ovarian reserve.
• Antral Follicle Count (AFC)—transvaginal ultrasound on days 2–4 of the cycle to assess the number of basal follicles.
• Thyroid function (TSH, FT3, FT4)—thyroid abnormalities are a common cause of menstrual irregularities.
• Metabolic screening (blood glucose, insulin, lipids)—especially applicable to patients with PCOS.

Layer 2: Ovulation Function Assessment

Determine whether ovulation occurs through progesterone measurement or serial ultrasound monitoring. If ovulation occurs but cycles are irregular, the impact on the IVF process is usually minimal; if there is no ovulation, medication is needed to establish an artificial cycle before starting the IVF cycle.

Layer 3: Uterine and Endometrial Evaluation

• Hysteroscopy—to rule out endometrial polyps, adhesions, chronic endometritis, and other pathologies.
• Endometrial biopsy—performed if endometritis or abnormal endometrial receptivity is suspected.

Module D: Differences Across Age Groups

Examination and Protocol Differences by Age Group

Age is a key variable influencing IVF strategies for patients with irregular menstruation. The weight of etiological factors and protocol choices differ significantly across age groups.

From clinical observation, in patients under 35 with irregular menstruation, the cause is mostly PCOS. These patients usually have a good number of follicles, but quality needs attention, and OHSS must be prevented during stimulation. In patients over 40 with irregular periods, ovulatory dysfunction due to diminished ovarian reserve is more common, requiring gentler protocols to avoid overstimulation.

Module E: Differences Across Countries

Characteristics of Ovulation Induction Protocols in Different Countries

When choosing overseas IVF, patients with irregular menstruation will find differences in ovulation induction strategies across countries, mainly in medication habits and protocol preferences.

The main difference in protocols across countries lies in the management of poor ovarian responders. The USA focuses on genetic testing and individualized medication, Japan has accumulated extensive experience in mild stimulation, while Thailand and Malaysia balance flexibility within standardized processes. The choice should consider your ovarian reserve, age, and budget.

Module G: Most Easily Overlooked Details

Most Easily Overlooked Details

In the preparation for overseas IVF in patients with irregular menstruation, the following details are often neglected but directly affect the smoothness of the process.

• Timing of hormone tests—It is difficult for patients with irregular periods to determine cycle days 2–4. If there is prolonged amenorrhea, blood can be drawn at any time, but an ultrasound must be done simultaneously to check endometrial thickness and follicle status, allowing the doctor to judge whether it is suitable as a baseline.
• AMH is not affected by the cycle—Regardless of menstrual regularity, AMH can be checked anytime; it is recommended to do it as early as possible as it is the most stable indicator of ovarian reserve.
• Male partner’s semen analysis should be done early—Patients with irregular periods often focus on themselves and neglect the partner’s concurrent tests. Semen analysis requires 3–5 days of abstinence; plan ahead.
• Timeliness of chromosomal testing—Karyotyping results usually take 2–4 weeks; if PGT is involved, it takes longer. Complete this 2 months before starting the cycle.
• Passport validity—An overseas IVF cycle usually takes 1–3 months, and complex cases may take longer. Ensure passport validity is at least 6 months to avoid expiration mid-cycle.

Module H: Common Pitfalls

Common Pitfalls

Based on real clinical situations, patients with irregular menstruation undergoing overseas IVF are prone to problems in the following areas.

• Blindly taking regulating medications—Some patients follow folk remedies or self-administer Chinese patent medicines or supplements to “regulate periods.” Some contain hormones that can interfere with subsequent stimulation medications, even leading to cycle cancellation. Any regulation should be under a doctor’s guidance.
• Ignoring insulin resistance—About 50%–70% of PCOS patients have insulin resistance. If left untreated, it can affect egg quality and endometrial receptivity. An oral glucose tolerance test (OGTT) is recommended in advance.
• Misjudging the start time for stimulation—Before starting the cycle, patients with irregular periods need to determine “when is cycle day 2–4.” If in an amenorrheic state, the doctor will use dydrogesterone or progesterone to establish an artificial cycle before starting; do not judge on your own.
• Wrong transfer protocol choice—If patients with irregular periods choose a natural cycle transfer, it is difficult to accurately capture ovulation timing, easily missing the window. For frozen embryo transfer, an artificial cycle protocol is preferred, using medication to control endometrial growth, making timing more controllable.
• Neglecting thyroid function—Thyroid dysfunction (especially subclinical hypothyroidism) is a common cause of irregular menstruation and can also affect embryo implantation. Keeping TSH below 2.5 mIU/L is more favorable for pregnancy.

Module J: Timeline Planning

Timeline and Process Planning

The timeline for overseas IVF in patients with irregular menstruation needs to allow more flexibility. Below is a reference timeline.

Phase 1: Domestic Examination and Evaluation (1–2 months)

• Any time during cycle: AMH, thyroid function, metabolic screening, chromosomal testing
• After determining cycle (or after medication to establish cycle): hormone panel, antral follicle count
• Male partner’s semen analysis, infectious disease screening
• Hysteroscopy (if indicated)
• File creation, document preparation (passport, notarized marriage certificate, translations)

Phase 2: Overseas Stimulation and Egg Retrieval (2–4 weeks)

• After arrival overseas: confirm menstrual cycle, start ovulation induction (usually 10–14 days)
• Egg retrieval surgery: 1 day
• Embryo culture: 5–6 days (if PGT is done, results take 2–4 weeks)

Phase 3: Frozen Embryo Transfer (1–2 months later)

• Artificial cycle preparation of endometrium: 12–18 days
• Transfer surgery: 1 day
• Pregnancy test 12–14 days after transfer

Module Q: Frequently Asked Questions

Frequently Asked Questions

Below are the most common questions from patients with irregular menstruation in clinical consultations.

Q1: Does irregular menstruation mean poor ovarian function?

Not necessarily. There is no direct correlation between irregular menstruation and ovarian function. Young PCOS patients may have oligomenorrhea but high AMH and sufficient follicle numbers. Conversely, some women with regular cycles may already have diminished ovarian reserve. The key indicators are AMH, FSH, and antral follicle count.

Q2: Do I need to regulate my periods to be regular before going abroad for IVF?

No, and it is not recommended. Irregular menstruation itself is not a contraindication for IVF. The stimulation medications in the IVF process replace the natural cycle, so there is no need to regulate periods first. The important thing is to complete a systematic evaluation, identify the cause of irregularity, and rule out organic pathologies that could affect embryo implantation.

Q3: Is the success rate of overseas IVF low for PCOS?

PCOS patients usually have a good number of retrieved eggs, but egg maturity and embryo quality need attention. If insulin resistance is managed with medication, weight is controlled, and a suitable stimulation protocol (e.g., antagonist or follicular phase long protocol) is chosen, the clinical pregnancy rate is not lower than for other etiologies. However, the risk of OHSS must be monitored.

Q4: Does irregular menstruation affect luteal phase support after transfer?

When using an artificial cycle for frozen embryo transfer, luteal phase support is provided by exogenous progesterone (vaginal gel, oral dydrogesterone, or progesterone injections) and is independent of the body’s own menstrual regularity. Therefore, irregular menstruation does not affect the effectiveness of luteal support.

Q5: Is there still a chance for overseas IVF if I have low AMH and irregular periods?

Yes, there is a chance. Low AMH indicates reduced ovarian reserve, but it does not mean no eggs can be retrieved. Such patients are suitable for mild stimulation or natural cycle protocols, aiming to obtain a few but good-quality embryos. At the same time, investigate whether the irregular menstruation is related to thyroid or metabolic abnormalities; correcting these factors may improve egg quality.

Closing: Doctor’s Advice